United Therapeutics Corp.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2008 | $281.5M | $-82.1M | $-49.3M |
| FY2009 | $358.9M | $25.8M | $19.5M |
| FY2010 | $592.9M | $171.3M | $105.9M |
| FY2011 | $743.2M | $317.8M | $217.9M |
| FY2012 | $916.1M | $421.6M | $304.4M |
| FY2013 | $1.12B | $292.5M | $174.6M |
| FY2014 | $1.29B | $538.8M | $340.1M |
| FY2015 | $1.47B | $699.0M | $651.6M |
| FY2016 | $1.60B | $1.06B | $713.7M |
| FY2017 | $1.73B | $814.9M | $417.9M |
| FY2018 | $1.63B | $805.4M | $589.2M |
| FY2019 | $1.45B | $-187.6M | $-104.5M |
| FY2020 | $1.48B | $593.6M | $514.8M |
| FY2021 | $1.69B | $555.9M | $475.8M |
| FY2022 | $1.94B | $979.7M | $727.3M |
| FY2023 | $2.33B | $1.18B | $984.8M |
| FY2024 | $2.88B | $1.38B | $1.20B |
| FY2025 | $3.18B | $1.49B | $1.33B |
The intelligent investor is a realist who sells to optimists and buys from pessimists.